A Study of LY900014 in Participants With Type 1 Diabetes

Clinical trial NCT03214367 · COMPLETED

Trial details

NCT number: NCT03214367
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2017-07-17
Primary completion: 2018-09-06
Enrollment: 1392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.